14.11.2012 Views

Program Book

Program Book

Program Book

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

control group received both an intravenous and oral placebo. Patients<br />

in both groups had access to standard medications for pain on a<br />

sliding scale as needed based on pain severity. Nurses were blinded<br />

to the patient’s group status. Patients were asked to score their pain<br />

experience using a visual analogue scale (VAS) three times per day<br />

during the inpatient admission while the plaque was in place as well as<br />

once the day after plaque removal and once at the 2-week postoperative<br />

visit. The nurse administering the steroid or placebo to the patient<br />

separately scored his/her perception of the patients’ pain using the<br />

Wong-Baker FACES scale.<br />

Results. Preliminary results indicate that there is a decreased pain in<br />

the patients in the steroid group both during plaque application and<br />

in the immediate post-operative period. Patient recruitment and data<br />

analysis is ongoing and full results will be presented at the ISOO.<br />

Conclusions. The use of intravenous and oral steroids should be<br />

considered both during the treatment period and post-operatively for<br />

plaque patients given the severe discomfort that many plaque patients<br />

experience.<br />

Financial disclosure. None<br />

1623 UM35<br />

UVEAL MELANOMA AMONG FINNISH CHILDREN AND<br />

ADOLESCENTS<br />

Rana’a Aljamal, Tero Kivelä (ranaa.aljamal@hus.fi)<br />

Departement of Ophthalmology, Ocular Oncology Service, Helsinki<br />

University Central Hospital,<br />

Purpose. To report uveal melanoma (UM) before the age of 25 years in<br />

Finland, a high incidence region for this cancer.<br />

Methods. A population-based study identified 24 patients (0.3%), aged<br />

between 13 and 24 years at diagnosis, treated in our hospital in 1963-<br />

2006. They were divided in two groups, the first consisted of 11 patients<br />

(9 females, 2 males) enucleated before 1997. The second was treated by<br />

irradiation after 1991, consisting of 11 patients (9 females, 2 males). Two<br />

other patients underwent local resection (male and female).<br />

Results. Tumour height was 4-11 mm (mean, 7) in the first and 4.4-13.7<br />

mm (mean, 8.5) in the second group and largest basal diameter ranged<br />

from 5-16 mm (mean, 10) and 2.5- 21 mm (mean, 15), respectively. Four<br />

patients died, 3 of UM (after 4, 12 and 21 years). All were female with<br />

spindle tumours. In the second group, 2 females died of UM (after 3<br />

and 4 years).<br />

Conclusions. UM is rarely seen among young children and adolescents.<br />

In this small series, females outnumbered males.<br />

Financial disclosure. None<br />

UVEAL MELANOMA<br />

Abstracts<br />

107<br />

406 UM 36<br />

RESULTS OF MELANOMA BRACHYTHERAPY IN AR-<br />

GENTINA<br />

Arturo Irarrazaval, Pablo Cazon (artuira@consultoresoftalmologicos.<br />

com)<br />

Consultores Oftalmologicos<br />

Purpose. To present our experience in 58 cases of choroidal melanoma<br />

treated with brachytherapy in Argentina.<br />

Methods. Retrospective study of the charts of 58 patients treated with<br />

brachytherapy.<br />

Results. There were, till today, 3 cases of metastases. We had 3<br />

recurrences, and could preserve the globe in 52 cases. 31 of our patients<br />

had a final visual acuity of 20/400 or better.<br />

Conclusions. Conservative treatment of melanoma, using brachytherapy,<br />

has good results in preserving the eye, without increase in mortality,<br />

and in more than half the patients, retaining useful vision.<br />

Financial disclosure. None

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!